Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin in classic or endemic Kaposi's sarcoma
NCT02212639Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2014
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of digoxin in Kaposi's sarcoma (KS), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
digoxin
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT02212639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212639.